SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-027838
Filing Date
2023-08-11
Accepted
2023-08-11 16:16:15
Documents
69
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1020340
2 ex10-6.htm EX-10.6 360246
3 ex10-6_001.jpg GRAPHIC 14664
4 ex10-6_002.jpg GRAPHIC 4376
5 ex10-6_003.jpg GRAPHIC 4544
6 ex31-1.htm EX-31.1 11723
7 ex31-2.htm EX-31.2 11959
8 ex32-1.htm EX-32.1 7465
9 ex32-2.htm EX-32.2 7607
  Complete submission text file 0001493152-23-027838.txt   4686678

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE ogen-20230630.xsd EX-101.SCH 34034
11 XBRL CALCULATION FILE ogen-20230630_cal.xml EX-101.CAL 47859
12 XBRL DEFINITION FILE ogen-20230630_def.xml EX-101.DEF 119758
13 XBRL LABEL FILE ogen-20230630_lab.xml EX-101.LAB 253768
14 XBRL PRESENTATION FILE ogen-20230630_pre.xml EX-101.PRE 204945
63 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 517871
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 231164329
SIC: 2834 Pharmaceutical Preparations